KeyBank National Association’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$464K Sell
3,091
-60
-2% -$6.53K ﹤0.01% 958
2026
Q1
$291K Sell
3,151
-3,038
-49% -$305K ﹤0.01% 1052
2025
Q4
$632K Sell
6,189
-72
-1% -$6.44K ﹤0.01% 711
2025
Q3
$391K Buy
+6,261
New +$341K ﹤0.01% 899
2024
Q3
Sell
-6,933
Closed -$200K 1146
2024
Q2
$200K Buy
+6,933
New +$161K ﹤0.01% 1055
2023
Q4
Sell
-6,933
Closed -$205K 1086
2023
Q3
$205K Buy
6,933
+680
+11% +$23.9K ﹤0.01% 971
2023
Q2
$224K Buy
+6,253
New +$180K ﹤0.01% 976

Other funds holding GH

KeyBank National Association's GH Position: Q2 2026 in Review

KeyBank National Association reduced its Guardant Health (GH) stake by 1.9% in Q2 2026, selling an estimated $6.53K and leaving 3,091 shares worth $464K. The position accounts for ﹤0.01% of the portfolio, ranked #958.

KeyBank National Association first reported a position in GH in Q2 2023 and has held it in 7 quarters since. The position peaked at $632K in Q4 2025. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • KeyBank National Association held 3,091 shares of Guardant Health worth $464K as of Q2 2026.
  • KeyBank National Association sold 60 Guardant Health shares in Q2 2026, an estimated $6.53K.
  • Guardant Health made up ﹤0.01% of KeyBank National Association's portfolio in Q2 2026, its #958 holding.
  • KeyBank National Association first reported a position in Guardant Health in Q2 2023 and has held it in 7 quarters since.
  • KeyBank National Association's Guardant Health position peaked at $632K in Q4 2025.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on KeyBank National Association's 13F filing for Q2 2026, filed 28 Jul 2026.